Dashboard
Dividend Tracker
My Portfolio
Portfolios
Investors
Analysts
Community
Calendars
Economic Calendar
Dividend Calendar
Earnings Calendar
Splits Calendar
IPO Calendar
Markets
Stocks
Indices
Forex
Crypto
Commodities
News
Sign Up
Sign In
Your search results will appear here.
Light Mode
Dark Mode
Sign Up
Sign In
BB Biotech AG (BION)
Market Open
12 Jun, 15:20
SIX
All
(12)
DE
(6)
AT
(1)
CH
(1)
GB
(3)
US
(1)
SIX
Primary
LSE
OTC GREY
XHAN
XSTU
XDUS
XMUN
CBOE
CBOE
XETRA
XFRA
XWBO
43.
50
CHF
+0.7
+1.6355%
CHF
2.49B
Market Cap
9%
Div Yield
59,236
Volume
42.8
CHF
Previous Close
Watching
Watch
Add Transaction
Day Range
43
43.95
Year Range
29
49.65
Want to track
BION
and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Get Started For Free
Overview
Dividends
Earnings
Splits
Statistics
Historical Data
BB Biotech AG (BION) Statistics
Valuation metrics
Market Cap
2.49B
Enterprise value
2.04B
Trailing P/E (ttm)
-8.46
Forward P/E
-69.17
PEG ratio
0.03
Price/Sales (ttm)
-90.66
Price/Book (mrq)
0.9
Enterprise Value/Revenue
-77.24
Enterprise Value/EBITDA
-
Overview
Shares outstanding
55.15M
Float
-
Shares short
-
% Held by insiders
0%
% Held by institutions
0.18%
Average volume (10 days)
63.44K
Average volume (90 days)
96.59K
Price summary
52-Week low
29
52-Week high
49.65
Beta
0.63
50-Day moving average
43.94
200-Day moving average
45.41
Dividends and splits
Forward annual dividend rate
9
Forward annual dividend yield
0.1982%
Trailing annual dividend rate
2.25
Trailing annual dividend yield
0.0517%
5-Year annual dividend yield
5.65%
Payout ratio
-0.35
Dividend Date
25 Mar 2026
Ex-Dividend Date
23 Mar 2026
Last split factor
5:1
Last split Date
29 Mar 2016
Financials
Fiscal year
Fiscal year ends
31 Dec 2025
Most recent quarter (mrq)
31 Mar 2026
Profitability
Profit margin
10.64%
Operating margin
1.72%
Operational effectiveness
Return on assets
-0.11%
Return on equity
-0.12%
Income Statement
Revenue (ttm)
616.88M
Revenue per share (ttm)
-0.48
Quarterly revenue growth (yoy)
13.11%
Gross profit (ttm)
616.88M
EBITDA
-
Net income to common (ttm)
797.69M
Diluted EPS (ttm)
-5.14
Quarterly earnings growth (yoy)
-1.28%
Balance Sheet
Total cash (mrq)
2.64B
Total cash per share (mrq)
6.5
Total debt (mrq)
-
Total Debt/Equity (mrq)
-
Current ratio (mrq)
336.03%
Book value per share (mrq)
48.07
Cash Flow
Cash flow statement
393.7M
Levered free cash flow (LFCF)
2.24B